Ticker Story
OTLK
Outlook Therapeutics, Inc.
3 independent mixed-direction signals · 90 days
3 of 8 signal types active in the last 90 days
You're seeing data as of 30 days ago — OTLKisn't one of this week's free-preview tickers.
Create a free account for current dataSignal Timeline
CVI Investments, Inc. — 13G, 9.9% of Outlook Therapeutics, Inc.
View primary source →Citadel Advisors — increase position (+1464%) · $626K
View primary source →Point72 Asset Management — exit position · $6K
View primary source →Outlook Therapeutics, Inc. — A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders
View primary source →GMS Ventures & Investments — 13D/A, 22.9% of Outlook Therapeutics, Inc.
View primary source →Mitchell P. Kopin — 13G, 4.99% of Outlook Therapeutics, Inc
View primary source →Sphera Funds Management Ltd. — 13G/A, 4.69% of Outlook Therapeutics, Inc.
View primary source →Empery Asset Management, LP — 13G/A, 4.99% of Outlook Therapeutics, Inc.
View primary source →Great Point Partners, LLC — 13G/A, 4.99% of Outlook Therapeutics, Inc.
View primary source →TANG CAPITAL MANAGEMENT, LLC — 13G/A, 3.4% of Outlook Therapeutics, Inc.
View primary source →⚠ Detection and context from official public sources — not financial advice, not a prediction.